Alabama HB79 prohibits the State Board of Pharmacy and employers from disciplining pharmacists for recommending or dispensing off-label medical.
Alabama HB79 aims to protect pharmacists from disciplinary actions by the State Board of Pharmacy or employers for recommending or dispensing off-label medical treatments. The bill defines off-label medical treatment as the use of a drug, biological product, or device approved by the FDA in any manner other than the use approved by the FDA. It prohibits the Board of Pharmacy from taking adverse actions against a pharmacist's license based on such recommendations or dispensing.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.